Hydrochloric Acid → 2-{6-[2-(Dimethylamino)ethoxy]pyrimidin-4-yl}-4-pyridin-3-yl-1,2-dihydro-3H-pyrazol-3-one hydrochloride

HRID 37901

Reaktionsgleichung

Reaktionsgleichung von HRID 37901
[H-].[Na+].[CH3:3][N:4]([CH3:8])[CH2:5][CH2:6][OH:7].[Cl:9][C:10]1[N:15]=[CH:14][N:13]=[C:12]([N:16]2[C:20](=[O:21])[C:19]([C:22]3[CH:23]=[N:24][CH:25]=[CH:26][CH:27]=3)=[CH:18][NH:17]2)[CH:11]=1.Cl>C1COCC1.[I-].C([N+](CCCC)(CCCC)CCCC)CCC.O>[ClH:9].[CH3:3][N:4]([CH3:8])[CH2:5][CH2:6][O:7][C:10]1[N:15]=[CH:14][N:13]=[C:12]([N:16]2[C:20](=[O:21])[C:19]([C:22]3[CH:23]=[N:24][CH:25]=[CH:26][CH:27]=3)=[CH:18][NH:17]2)[CH:11]=1

Komponenten

8

Versuchsvorschrift

99 mg (0.4 mmol, 60% in mineral oil) of sodium hydride are added to a solution of 35 μl (31 mg, 0.4 mmol) of N,N-dimethylethanolamine and 2 ml of anhydrous THF, and the mixture is stirred for 10 min 100 mg (0.4 mmol) of the compound from Example 23, suspended in 3 ml of anhydrous THF, and 6 mg (0.02 mmol) of tetra-n-butylammonium iodide are added, and the mixture is stirred at RT for 16 h. 1 N hydrochloric acid and water are then added, the mixture is concentrated on a rotary evaporator and the residue is stirred in methanol. The precipitated solid is filtered off, and the filtrate is concentrated under reduced pressure. The filter residue is stirred in diethyl ether, the precipitate is filtered off and the filter residue is purified further by preparative HPLC (RP18 column; mobile phase: acetonitrile/water gradient with addition of 0.1% formic acid). The resulting formate salt of the target compound is converted into the hydrochloride by addition of 2 ml 1 M hydrochloric acid and reconcentration.

Aufarbeitung

  1. concentrationthe mixture is concentrated on a rotary evaporator
  2. stirringthe residue is stirred in methanol
  3. filtrationThe precipitated solid is filtered off
  4. concentrationthe filtrate is concentrated under reduced pressure
  5. stirringThe filter residue is stirred in diethyl ether
  6. filtrationthe precipitate is filtered off
  7. customthe filter residue is purified further by preparative HPLC (RP18 column; mobile phase: acetonitrile/water gradient with addition of 0.1% formic acid)
  8. additionThe resulting formate salt of the target compound is converted into the hydrochloride by addition of 2 ml 1 M hydrochloric acid and reconcentration

Quellen und Nachweise

ORD-Eintrag
ord-c39be85efd1e4e9797d004187cae004c
Quelldatensatz
uspto-grants-2013_09
Patentnummer
US08524699B2

Verknüpfte Notizen

Wird geladen…